文献速递心血管MR

功能性三尖瓣反流中的非缺血性室间隔纤维化可对不良重构和预后提供增量分层

Nonischemic Septal Fibrosis in Functional Tricuspid Regurgitation Provides Incremental Stratification of Adverse Remodeling and Prognosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2025-07-03

研究纳入663例重度及以上功能性三尖瓣反流患者,用心脏磁共振晚期钆增强识别非缺血性室间隔纤维化(NIsF),29.4%存在NIsF。NIsF与左右心室扩大、收缩功能降低及三尖瓣反流严重度增加相关,且独立关联全因死亡(HR 1.79),提供超越常规风险标志物的增量预后价值。

要点

  • 功能性三尖瓣反流患者中29.4%存在非缺血性室间隔纤维化(NIsF)。
  • NIsF与左室和右室容积增大、收缩功能降低及三尖瓣反流严重度增加相关(均P<0.001)。
  • NIsF独立关联全因死亡(HR 1.79,95%CI 1.26-2.56),超越年龄、反流严重度、右室功能与扩张等常规标志物。

核心结论

  • 在重度及以上功能性三尖瓣反流患者中,NIsF是不良右心腔重构的重要标志物,并提供超越常规风险标志物的增量预后价值。

研究设计与样本

  • 研究为对接受 comprehensive 心脏磁共振(CMR)评估的重度及以上功能性三尖瓣反流患者进行的队列分析,共663例,平均年龄63.8±16.0岁,53%为男性;以晚期钆增强(LGE)识别NIsF,定义为室间隔中壁或心外膜区的高强化;以电影CMR测量左右心功能与几何指标;随访获取全因死亡数据。

关键影像表现/征象

  • NIsF定义为室间隔中壁或心外膜区晚期钆增强高强化。
  • NIsF与左室和右室容积增大、收缩功能降低及三尖瓣反流严重度增加相关(均P<0.001)。

诊断标准与关键数值

  • 三尖瓣反流反流分数随NIsF范围逐步增加:无NIsF为34.9%±1.5%,1个节段为38.1%±13.0%,2个节段为40.8%±13.8%(P<0.001)。
  • NIsF与全因死亡的独立关联:HR 1.79(95%CI 1.26-2.56),P=0.001,校正年龄、三尖瓣反流严重度、右室功能障碍和扩张后仍显著。
  • Kaplan-Meier分析显示NIsF患者死亡风险显著高于无NIsF患者(P<0.001)。
  • 平均随访4.3±4.3年期间25.3%患者死亡。

临床应用与阅片要点

  • 在功能性三尖瓣反流患者的CMR评估中,应关注室间隔中壁或心外膜区晚期钆增强高强化以识别NIsF。
  • NIsF的存在与范围可提示更严重的心腔重构和更高的死亡风险,可作为常规风险标志物之外的增量分层信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Functional tricuspid regurgitation (TR) arises from impaired valve integrity resulting from contractile dysfunction, chamber dilation, or myocardial tissue alterations. Whereas right ventricular (RV) dysfunction is a recognized driver of adverse outcomes in TR, the impact of myocardial tissue injury, particularly nonischemic septal fibrosis (NIsF), remains largely unexplored.

OBJECTIVES: This study aims to evaluate the association of NIsF with adverse right-sided chamber remodeling and to assess its incremental prognostic value for mortality in patients with functional TR.

METHODS: Patients with advanced (≥ moderate) functional TR underwent comprehensive cardiac magnetic resonance (CMR) evaluation. Late gadolinium enhancement (LGE) was used to identify NIsF, defined as hyperenhancement in the midmyocardial or epicardial regions of the interventricular septum. Cine CMR measured functional and geometric indices of the left and right sides of the heart. Follow-up data were obtained for all-cause mortality.

RESULTS: A total of 663 patients with advanced TR (mean age: 63.8 ± 16.0 years; 53% male) were studied, and 29.4% were found to have NIsF. NIsF was strongly associated with adverse chamber remodeling, including larger left ventricular and RV volumes, reduced systolic function, and increased TR severity (all P < 0.001). TR regurgitant fraction increased stepwise with NIsF extent (no NIsF, 34.9% ± 1.5%; 1 segment, 38.1% ± 13.0%; 2 segments, 40.8% ± 13.8%; P < 0.001). Over a mean follow-up of 4.3 ± 4.3 years, 25.3% of patients died. NIsF was independently associated with mortality (HR: 1.79 [95% CI: 1.26-2.56]; P = 0.001), even after adjusting for conventional risk markers, including age, TR severity, RV dysfunction, and dilation. Kaplan-Meier analysis demonstrated significantly higher mortality risk among patients with NIsF compared with patients without NIsF (P < 0.001).

CONCLUSIONS: Among patients with advanced TR, NIsF is an important marker of adverse right-sided chamber remodeling and provides incremental prognostic utility beyond conventional risk markers.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Villar-Calle P, Pai V, Zhang RS, et al. Nonischemic Septal Fibrosis in Functional Tricuspid Regurgitation Provides Incremental Stratification of Adverse Remodeling and Prognosis. JACC Cardiovasc Imaging. 2025. PMID: 40608040. doi:10.1016/j.jcmg.2025.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。